Improving ablation strategies for the treatment of atrial fibrillation

References

• Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 155(5), 469–473 (1995).
   PubMedGoogle Scholar
• Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18), 2370–2375 (2001).
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98(10), 946–952 (1998).
   PubMed Web of Science ®Google Scholar
• Nieuwlaat R, Prins MH, Le Heuzey JY et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur. Heart J. 29(9), 1181–1189 (2008).
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Bailey KR et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J. Am. Coll. Cardiol. 49(9), 986–992 (2007).
   PubMed Web of Science ®Google Scholar
• Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch. Intern. Med. 158(3), 229–234 (1998).
   PubMedGoogle Scholar
• Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am. J. Med. 98(5), 476–484 (1995).
   PubMed Web of Science ®Google Scholar
• Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1(8532), 526–529 (1987).
   PubMedGoogle Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8), 983–988 (1991).
   PubMed Web of Science ®Google Scholar
• [No authors listed]. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 154(13), 1449–1457 (1994).
   PubMed Web of Science ®Google Scholar
• Waktare JE, Camm AJ. Acute treatment of atrial fibrillation: why and when to maintain sinus rhythm. Am. J. Cardiol. 81(5A), 3C–15C (1998).
   Google Scholar
• Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 90(3), 286–292 (2004).
   PubMed Web of Science ®Google Scholar
• Ringborg A, Nieuwlaat R, Lindgren P et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 10(4), 403–411 (2008).
   PubMed Web of Science ®Google Scholar
• Gillis AM, Verma A, Talajic M, Nattel S, Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can. J. Cardiol. 27(1), 47–59 (2011).
   PubMedGoogle Scholar
• Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm, 9(4), 632–696 e621 (2012).
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(7), e257–e354 (2006).
   PubMed Web of Science ®Google Scholar
• Roy D, Talajic M, Dorian P et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N. Engl. J. Med. 342(13), 913–920 (2000).
   PubMed Web of Science ®Google Scholar
• Singh SN, Singh BN, Reda DJ et al. Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol–Amiodarone Fibrillation Efficacy Trial [Safe-T]). Am. J. Cardiol. 92(4), 468–472 (2003).
   PubMedGoogle Scholar
• Roden DM. Mechanisms and management of proarrhythmia. Am. J. Cardiol. 82(4A), 49I–57I (1998).
   PubMed Web of Science ®Google Scholar
• Doyle JF, Ho KM. Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis. Mayo Clin. Proc. 84(3), 234–242 (2009).
   PubMedGoogle Scholar
• Nademanee K, Schwab MC, Kosar EM et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J. Am. Coll. Cardiol. 51(8), 843–849 (2008).
   PubMed Web of Science ®Google Scholar
• Corley SD, Epstein AE, DiMarco JP et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109(12), 1509–1513 (2004).
   PubMed Web of Science ®Google Scholar
• de Waroux JB, Talajic M, Khairy P et al. Pulmonary vein isolation for the treatment of atrial fibrillation: past, present and future. Future Cardiol. 6(1), 51–66 (2010).
   PubMedGoogle Scholar
• Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J. Am. Coll. Cardiol. 42(2), 185–197 (2003).
   PubMed Web of Science ®Google Scholar
• Cheema A, Dong J, Dalal D et al. Long-term safety and efficacy of circumferential ablation with pulmonary vein isolation. J. Cardiovasc. Electrophysiol. 17(10), 1080–1085 (2006).
   PubMedGoogle Scholar
• Macle L, Jais P, Weerasooriya R et al. Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J. Cardiovasc. Electrophysiol. 13(11), 1067–1073 (2002).
   PubMedGoogle Scholar
• Karch MR, Zrenner B, Deisenhofer I et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111(22), 2875–2880 (2005).
   PubMedGoogle Scholar
• Jais P, Hocini M, Hsu LF et al. Technique and results of linear ablation at the mitral isthmus. Circulation 110(19), 2996–3002 (2004).
   PubMedGoogle Scholar
• Kottkamp H, Tanner H, Kobza R et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J. Am. Coll. Cardiol. 44(4), 869–877 (2004).
   PubMed Web of Science ®Google Scholar
• Oral H, Knight BP, Tada H et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 105(9), 1077–1081 (2002).
   PubMed Web of Science ®Google Scholar
• Pappone C, Vicedomini G, Augello G et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Circ. Arrhythm. Electrophysiol. 4(6), 808–814 (2011).
   PubMed Web of Science ®Google Scholar
• Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J. Am. Coll. Cardiol. 48(11), 2340–2347 (2006).
   PubMed Web of Science ®Google Scholar
• Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293(21), 2634–2640 (2005).
   PubMed Web of Science ®Google Scholar
• Jais P, Cauchemez B, Macle L et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118(24), 2498–2505 (2008).
   PubMed Web of Science ®Google Scholar
• Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med. 354(9), 934–941 (2006).
   PubMed Web of Science ®Google Scholar
• Packer DL, Irwin JM, Champagne J et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front STOP-AF pivotal trial. J. Am. Coll. Cardiol. 55, E3015–E3016 (2010).
   Google Scholar
• Krittayaphong R, Raungrattanaamporn O, Bhuripanyo K et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J. Med. Assoc. Thai. 86(Suppl. 1), S8–S16 (2003).
   PubMedGoogle Scholar
• Noheria A, Kumar A, Wylie JV Jr, Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch. Intern. Med. 168(6), 581–586 (2008).
   PubMedGoogle Scholar
• Stabile G, Bertaglia E, Senatore G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur. Heart J. 27(2), 216–221 (2006).
   PubMedGoogle Scholar
• Wilber DJ, Pappone C, Neuzil P et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303(4), 333–340 (2010).
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Crandall BG, Weiss JP et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J. Cardiovasc. Electrophysiol. 22(8), 839–845 (2011).
   PubMed Web of Science ®Google Scholar
• Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ. Arrhythm. Electrophysiol. 2(6), 626–633 (2009).
   PubMed Web of Science ®Google Scholar
• Wokhlu A, Monahan KH, Hodge DO et al. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. J. Am. Coll. Cardiol. 55(21), 2308–2316 (2010).
   PubMed Web of Science ®Google Scholar
• Chang HY, Lo LW, Lin YJ et al. Long-term outcome of catheter ablation in patients with atrial fibrillation originating from the superior vena cava. J. Cardiovasc. Electrophysiol. 23(9), 955–961 (2012).
   PubMedGoogle Scholar
• Lin D, Frankel DS, Zado ES et al. Pulmonary vein antral isolation and nonpulmonary vein trigger ablation without additional substrate modification for treating longstanding persistent atrial fibrillation. J. Cardiovasc. Electrophysiol. 23(8), 806–813 (2012).
   PubMed Web of Science ®Google Scholar
• Chen SA, Tai CT. Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci. J. Cardiovasc. Electrophysiol. 16(2), 229–232 (2005).
   PubMed Web of Science ®Google Scholar
• Dixit S, Marchlinski FE, Lin D et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ. Arrhythm. Electrophysiol. 5(2), 287–294 (2012).
   PubMedGoogle Scholar
• Haissaguerre M, Gencel L, Fischer B et al. Successful catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 5(12), 1045–1052 (1994).
   PubMed Web of Science ®Google Scholar
• Verma A. The techniques for catheter ablation of paroxysmal and persistent atrial fibrillation: a systematic review. Curr. Opin. Cardiol. 26(1), 17–24 (2011).
   PubMedGoogle Scholar
• Hocini M, Jais P, Sanders P et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation 112(24), 3688–3696 (2005).
   PubMedGoogle Scholar
• Gaita F, Caponi D, Scaglione M et al. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ. Arrhythm. Electrophysiol. 1(4), 269–275 (2008).
   PubMed Web of Science ®Google Scholar
• Wazni O, Marrouche NF, Martin DO et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation 108(20), 2479–2483 (2003).
   PubMedGoogle Scholar
• Verma A, Mantovan R, Macle L et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur. Heart J. 31(11), 1344–1356 (2010).
   PubMed Web of Science ®Google Scholar
• Estner HL, Hessling G, Ndrepepa G et al. Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation. Europace 10(11), 1281–1287 (2008).
   PubMedGoogle Scholar
• Deisenhofer I, Estner H, Reents T et al. Does electrogram guided substrate ablation add to the success of pulmonary vein isolation in patients with paroxysmal atrial fibrillation? A prospective, randomized study. J. Cardiovasc. Electrophysiol. 20(5), 514–521 (2009).
   PubMedGoogle Scholar
• Di Biase L, Elayi CS, Fahmy TS et al. Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques. Circ. Arrhythm. Electrophysiol. 2(2), 113–119 (2009).
   PubMed Web of Science ®Google Scholar
• Elayi CS, Verma A, Di Biase L et al. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm. 5(12), 1658–1664 (2008).
   PubMed Web of Science ®Google Scholar
• Oral H, Chugh A, Yoshida K et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J. Am. Coll. Cardiol. 53(9), 782–789 (2009).
   PubMed Web of Science ®Google Scholar
• Shah AJ, Hocini M, Xhaet O et al. Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study. J. Am. Coll. Cardiol. 62(10), 889–897 (2013).
   PubMed Web of Science ®Google Scholar
• Ganesan AN, Kuklik P, Lau DH et al. Bipolar electrogram shannon entropy at sites of rotational activation: implications for ablation of atrial fibrillation. Circ. Arrhythm. Electrophysiol. 6(1), 48–57 (2013).
   PubMedGoogle Scholar
• Cuculich PS, Wang Y, Lindsay BD et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation 122(14), 1364–1372 (2010).
   PubMed Web of Science ®Google Scholar
• Kowalski M, Grimes MM, Perez FJ et al. Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation. J. Am. Coll. Cardiol. 59(10), 930–938 (2012).
   PubMed Web of Science ®Google Scholar
• Ouyang F, Antz M, Ernst S et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 111(2), 127–135 (2005).
   PubMed Web of Science ®Google Scholar
• Verma A, Kilicaslan F, Pisano E et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation 112(5), 627–635 (2005).
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Kuwahara T, Kobori A et al. Impact of adenosine-provoked acute dormant pulmonary vein conduction on recurrence of atrial fibrillation. J. Cardiovasc. Electrophysiol. 23(3), 256–260 (2012).
   PubMedGoogle Scholar
• Matsuo S, Yamane T, Date T et al. Reduction of AF recurrence after pulmonary vein isolation by eliminating ATP-induced transient venous re-conduction. J. Cardiovasc. Electrophysiol. 18(7), 704–708 (2007).
   PubMedGoogle Scholar
• Kumagai K, Muraoka S, Mitsutake C, Takashima H, Nakashima H. A new approach for complete isolation of the posterior left atrium including pulmonary veins for atrial fibrillation. J. Cardiovasc. Electrophysiol. 18(10), 1047–1052 (2007).
   PubMed Web of Science ®Google Scholar
• Macle L, Khairy P, Verma A et al. Adenosine following pulmonary vein isolation to target dormant conduction elimination (ADVICE): methods and rationale. Can. J. Cardiol. 28(2), 184–190 (2012).
   PubMed Web of Science ®Google Scholar
• Matsuo S, Yamane T, Date T et al. Dormant pulmonary vein conduction induced by adenosine in patients with atrial fibrillation who underwent catheter ablation. Am. Heart J. 161(1), 188–196 (2011).
   PubMedGoogle Scholar
• Eitel C, Hindricks G, Sommer P et al. Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block: the pace-and-ablate approach. Heart Rhythm 7(2), 157–164 (2010).
   PubMed Web of Science ®Google Scholar
• Steven D, Reddy VY, Inada K et al. Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm 7(3), 323–330 (2010).
   PubMed Web of Science ®Google Scholar
• Gula LJ, Massel D, Leong-Sit P et al. Does adenosine response predict clinical recurrence of atrial fibrillation after pulmonary vein isolation? J. Cardiovasc. Electrophysiol. 22(9), 982–986 (2011).
   PubMedGoogle Scholar
• Reddy VY, Shah D, Kautzner J et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 9(11), 1789–1795 (2012).
   PubMed Web of Science ®Google Scholar
• Neuzil P, Reddy VY, Kautzner J et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ. Arrhythm. Electrophysiol. 6(2), 327–333 (2013).
   PubMed Web of Science ®Google Scholar
• Calkins H, Reynolds MR, Spector P et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ. Arrhythm. Electrophysiol. 2(4), 349–361 (2009).
   PubMed Web of Science ®Google Scholar
• Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3(1), 32–38 (2010).
   PubMed Web of Science ®Google Scholar
• Dagres N, Hindricks G, Kottkamp H et al. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J. Cardiovasc. Electrophysiol. 20(9), 1014–1019 (2009).
   PubMed Web of Science ®Google Scholar
• Herrera Siklody C, Deneke T, Hocini M et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation comparison of different atrial fibrillation ablation technologies in a multicenter study. J. Am. Coll. Cardiol. 58(7), 681–688 (2011).
   PubMed Web of Science ®Google Scholar
• Gaita F, Leclercq JF, Schumacher B et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J. Cardiovasc. Electrophysiol. 22(9), 961–968 (2011).
   PubMed Web of Science ®Google Scholar
• Andrade JG, Khairy P, Guerra PG et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studies. Heart Rhythm 8(9), 1444–1451 (2011).
   PubMed Web of Science ®Google Scholar
• Wijffels MC, Van Oosterhout M, Boersma LV et al. Characterization of in vitro and in vivo lesions made by a novel multichannel ablation generator and a circumlinear decapolar ablation catheter. J. Cardiovasc. Electrophysiol. 20(10), 1142–1148 (2009).
   PubMed Web of Science ®Google Scholar
• Wittkampf FH, Nakagawa H. RF catheter ablation: lessons on lesions. Pacing Clin. Electrophysiol. 29(11), 1285–1297 (2006).
   PubMed Web of Science ®Google Scholar
• Weerasooriya R, Khairy P, Litalien J et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J. Am. Coll. Cardiol. 57(2), 160–166 (2011).
   PubMed Web of Science ®Google Scholar
• Khairy P, Chauvet P, Lehmann J et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 107(15), 2045–2050 (2003).
   PubMed Web of Science ®Google Scholar
• Shah D. Pulmonary vein isolation with the pulmonary vein ablation catheter (PVAC): is there a price to pay for a ‘simpler’, shorter procedure? Europace 12(4), 455–457 (2010).
   PubMedGoogle Scholar
• Yokoyama K, Nakagawa H, Wittkampf FH, Pitha JV, Lazzara R, Jackman WM. Comparison of electrode cooling between internal and open irrigation in radiofrequency ablation lesion depth and incidence of thrombus and steam pop. Circulation 113(1), 11–19 (2006).
   PubMed Web of Science ®Google Scholar
• Dukkipati SR, Kuck KH, Neuzil P et al. Pulmonary vein isolation using a visually-guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ. Arrhythm. Electrophysiol. 6(3), 467–472 (2013).
   PubMedGoogle Scholar
• O’Neill MD, Wright M, Knecht S et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur. Heart J. 30(9), 1105–1112 (2009).
   PubMed Web of Science ®Google Scholar